Skip to main content

Table 1 Baseline, demographic and disease-related parameters in childhood-onset Takayasu arteritis (c-TA) and healthy control group (CTRL).

From: Poor physical activity levels and cardiorespiratory fitness among patients with childhood-onset takayasu arteritis in remission: a cross‐sectional, multicenter study

  c-TA
(n = 17)
CTRL
(n = 17)
Demographic parameters
 Age (years) 18.4 (19) ± 3.44 (12–20) 18.5 (20) ± 3.50 (12–21)
 Sex, female, n (%) 11 (64.7) 11 (64.7)
 Height (m) 1.60 (1.57) ± 0.11 (1.46–1.64) 1.65 (1.62) ± 0.12 (1.40–1.74)
 Body weight (kg) 56.1 (54.8) ± 10.6 (40.6–63.8) 60.6 (62.0) ± 13.3 (31.2–71.0)
 BMI (kg/m2) 17.4 (17.3) ± 2.68 (13.4–18.8) 18.2 (18.5) ± 3.39 (11.0-20.4)
 Disease duration (years) 9.48 (10.1) ± 4.16 (7.07–11.8) NA
 Age at the disease onset (years) 9.25 (9.50) ± 4.62 (6.75-13.0) NA
TA classification n, (%)
 Type I 1 (5.88) NA
 Type IIa 1 (5.88) NA
 Type III 2 (11.7) NA
 Type IV 4 (23.5) NA
 Type V 9 (52.9) NA
 Arterial hypertension, n (%) 10 (58.8) NA
 Aortic stenosis, n (%) 9 (52.9) NA
Biological therapy, n (%)
 Infliximab 5 (29.4) NA
Non-biological therapy, n (%)
 Methotrexate 8 (47.0) NA
 Leflunomide 5 (29.4) NA
 Prednisone 4 (23.5) NA
 Enalapril 5 (29.4) NA
 Amlodipine 3 (17.2) NA
Disease score
 ITAS score 0.0 (0.0–0.0) NA
 PVAS score 0.0 (0.0–1.0) NA
  1. Data are expressed as mean (median) ± SD (IQR 25–75) or n (%). BMI (body mass index), ITAS (indian takayasu’s arteritis activity score 2010), PVAS (Pediatric Vasculitis Activity Score), NA (not applicable).